Otwarty dostęp

DNA and BSA-Binding Studies of Dinuclear Palladium(II) Complexes with 1,5-Naphtiridine Bridging Ligands

Snezana Rajkovic

Snezana Rajkovic

University of Kragujevac, Faculty of Science, Department of ChemistryKragujevac, Serbia
Wyszukaj tego autora
Sciendo|Google Scholar
Rajkovic, Snezana
, 
Andjela A. Franich

Andjela A. Franich

University of Kragujevac, Faculty of Science, Department of ChemistryKragujevac, Serbia
Wyszukaj tego autora
Sciendo|Google Scholar
Franich, Andjela A.
, 
Vojislav Cupurdija

Vojislav Cupurdija

  • University of Kragujevac, Faculty of Medical Sciences, Department of Internal MedicineKragujevac, Serbia
  • University Clinical Center, Clinic for PulmonologyKragujevac, Serbia
Wyszukaj tego autora
Sciendo|Google Scholar
Cupurdija, Vojislav
 oraz 
Marija D. Zivkovic

Marija D. Zivkovic

University of Kragujevac, Faculty of Medical Sciences, Department of PharmacyKragujevac, Serbia
Wyszukaj tego autora
Sciendo|Google Scholar
Zivkovic, Marija D.
  
22 cze 2021
DNA and BSA-Binding Studies of Dinuclear Palladium(II) Complexes with 1,5-Naphtiridine Bridging Ligands's Cover Image
O artykule
Poprzedni artykuł
Następny artykuł
Zacytuj
Pobierz okładkę
Kategoria artykułu: Original Scientific Article
Data publikacji: 22 cze 2021
Zakres stron: 113 - 126
Otrzymano: 22 sty 2021
Przyjęty: 24 lut 2021
DOI: https://doi.org/10.2478/sjecr-2021-0030
Słowa kluczowe
© 2024 Snezana Rajkovic et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Figure 1.

Structural formulas of 1,5-naphthyridine (1,5-nphe), ethylenediamine (en) and 1,3-propylenediamine (1,3-pd), and dinuclear palladium(II) complexes Pd1 and Pd2.
Structural formulas of 1,5-naphthyridine (1,5-nphe), ethylenediamine (en) and 1,3-propylenediamine (1,3-pd), and dinuclear palladium(II) complexes Pd1 and Pd2.

Figure 2.

1H and 13C NMR spectra of [{Pd(en)Cl}2(μ-1,5-nphe)](NO3)2 (Pd1) and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)](NO3)2 (Pd2) complexes.
1H and 13C NMR spectra of [{Pd(en)Cl}2(μ-1,5-nphe)](NO3)2 (Pd1) and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)](NO3)2 (Pd2) complexes.

Figure 3.

UV-Vis spectra of dinuclear [{Pd(en)Cl}2 (μ-1,5-nphe)]2+ and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)]2+ complexes and free 1,5-nphe ligand.
UV-Vis spectra of dinuclear [{Pd(en)Cl}2 (μ-1,5-nphe)]2+ and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)]2+ complexes and free 1,5-nphe ligand.

Figure 4.

IR spectra of Pd1 and Pd2 complexes, KBr, 4000-450 cm−1.
IR spectra of Pd1 and Pd2 complexes, KBr, 4000-450 cm−1.

Figure 5.

Absorption spectra of [{Pd(en)Cl}2(μ-1,5-nphe)]2+ and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)]2+ complexes in 0.01 M phosphate buffer before and after addition of CT-DNA. [Pd(II) complex] = 4.51 · 10−5 M, [DNA] = (0 – 2.00) · 10−4 M.
Absorption spectra of [{Pd(en)Cl}2(μ-1,5-nphe)]2+ and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)]2+ complexes in 0.01 M phosphate buffer before and after addition of CT-DNA. [Pd(II) complex] = 4.51 · 10−5 M, [DNA] = (0 – 2.00) · 10−4 M.

Figure 6.

EtBr/CT-DNA emission spectra in the presence of [{Pd(en)Cl}2(μ-1,5-nphe)]2+ and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)]2+ complex. [EtBr] = 1.28 · 10−5 M, [DNA] = 1.28 · 10−5 M, [Pd(II) complex] = (0 – 1.28) · 10−5 M. Inserted graph: Dependence of I0/I from concentration [Q].
EtBr/CT-DNA emission spectra in the presence of [{Pd(en)Cl}2(μ-1,5-nphe)]2+ and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)]2+ complex. [EtBr] = 1.28 · 10−5 M, [DNA] = 1.28 · 10−5 M, [Pd(II) complex] = (0 – 1.28) · 10−5 M. Inserted graph: Dependence of I0/I from concentration [Q].

Figure 7.

BSA emission spectra in the presence of [{Pd(en)Cl}2(μ-1,5-nphe)]2+ and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)]2+ complexes. [BSA] = 1.60 · 10−6 M, [Pd(II) complex] = (0 – 4.00) · 10−5 M; λex = 295 nm. Inserted graph: Dependence of Io/I from concentration [Q].
BSA emission spectra in the presence of [{Pd(en)Cl}2(μ-1,5-nphe)]2+ and [{Pd(1,3-pd)Cl}2(μ-1,5-nphe)]2+ complexes. [BSA] = 1.60 · 10−6 M, [Pd(II) complex] = (0 – 4.00) · 10−5 M; λex = 295 nm. Inserted graph: Dependence of Io/I from concentration [Q].

Stern-Volmer constant (Ksv), quenching constant (kq), binding constant (Ka) and number of binding sites (n) for interactions between BSA and dinuclear Pd1 and Pd2 complexes_

complex Ksv · 105 (M−1) kq · 1012 (M−1s−1) Ka · 109 (M−1) n
[{Pd(en)Cl}2 (μ-1,5-nphe)]2+ (2.80 ± 0.03) (28 ± 2) (1.20 ± 0.05) 1.8
[{Pd(1,3-pd)Cl}2 (μ-1,5-nphe)]2+ (3.90 ± 0.04) (39 ± 1) (1.20 ± 0.02) 1.8

Stern-Volmer constant (Ksv), stability constant (Ka) and number of binding sites (n) of the investigated dinuclear palladium(II) complexes with CT-DNA

complex Ksv · 105 (M−1) Ka · 105 (M−1) n
[{Pd(en)Cl}2 (μ-1,5-nphe)]2+ (4.50 ± 0.04) (8.80 ± 0.02) 1.7
[{Pd(1,3-pd)Cl}2 (μ-1,5-nphe)]2+ (2.80 ± 0.06) (2.50 ± 0.05) 1.1

1H and 13C NMR chemical shifts (δ, ppm) for 1,5-naphthyridine (1,5-nphe), ethylenediamine (en), 1,3-propylenediamine (1,3-pd) and the corresponding dinuclear palladium(II) complexes

ligand/complex NMR shifts
1H 13C
H2, H6 H4, H8 H3, H7 alifatic protons C2, C6 C4, C8 C3, C7 C4a, C8a L
1,5-nphe 8.57 dd 7.89 d 7.48 dd 154 139 128 144
en 2.64 s (CH2) 45 (CH2)
Pd1 10.21 d 9.58 d 8.14 m 2.76 m (CH2) 160 147 130 143 50 (CH2)
1,3-pd 1.60 m (H2, CH2) 2.47 m (H1,H3,CH2) 29 (C2, CH2) 39 (C1,C3, H2)
Pd2 10.17 d 9.55 d 8.23 m 1.85 m (H2,CH2) 2.76 m (H1,H3,CH2) 160 146 131 143 30 (C2, CH2) 43,44 (C1,C3, CH2)

Internal binding constants (Kb), changes in Gibbs energy (ΔG) and hypochromism (H) of the investigated dinuclear palladium(II) complexes, Pd1 and Pd2, with CT-DNA

complex Kb · 104 (M−1) ΔG (kJ/mol) H
[{Pd(en)Cl}2 (μ-1,5-nphe)]2+ (7.50 ± 0.05) −28.93 22.42
[{Pd(1,3-pd)Cl}2 (μ-1,5-nphe)]2+ (4.00 ± 0.03) −27.31 25.77
Język:
Angielski
Częstotliwość wydawania:
4 razy w roku
Dziedziny czasopisma:
Medycyna, Medycyna kliniczna, Medycyna kliniczna, inne
Kanał RSS czasopisma